1. Vashishtha Vipin M
2. Kumar Chandra Mohan

9789390020607

10.5005/jp/books/18508_28

3/e

2021

29

1. Indian Academy of Pediatrics Advisory Committee on Vaccines and Immunization Practices; , Mangla Hospital and Research Center, Bijnor, Uttar Pradesh, India, National Convener, IAP Committee on Immunization, 2011-13, Mangla Hospital and Research Center, Bijnor, Uttar Pradesh, India, Mangla Hospital and Research Center, Bijnor, Uttar Pradesh, India; Indian Academy of Pediatrics Advisory Committee on Vaccines and Immunization Practices
2. Narayana Medical College and Hospitals, Nellore, AP, India, Hamdard Institute of Medical Sciences & Research and HAH Centenary Hospital, Hamdard University, New Delhi, India, Hamdard Institute of Medical Sciences and Research, New Delhi, India, All India Institute of Medical Sciences, Patna, Bihar, India, All India Institute of Medical Sciences, (AIIMS), Patna, Bihar, India

Japanese encephalitis vaccine, JE, key feature, human-to-human transmission, incubation period, epidemiology, acute encephalitis syndrome, AES, Universal Immunization Programme, UIP, mouse brain inactivated JE, plaque-forming unit, measles-mumps-rubella, MMR, oral polio vaccine, OPV